Organizational and budget impact model (OBIM) of SAME a new autotransfusion medical device
The results of this OBIM demonstrated the economic and organizational benefits of SAME for hospitals. This benefit results mainly of a reduction in the use of allogeneic blood products (RBCs, platelets).
Authors
- Nicolas Martelli (ORCID: https://orcid.org/0000-0001-5959-231X)
- Hélène Moutier
- J Placer
- Tess Martin (ORCID: https://orcid.org/0000-0002-1839-4306)
- S Bourguignon (ORCID: https://orcid.org/0000-0002-6400-8584)
Institutions
- Université Paris-Saclay (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Européen Georges-Pompidou (FR)
- Vitality Institute (US)
- Equality Now (US)
- European Hospital (IT)
Publication Details
- Journal
- Journal of Medical Economics
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1080/13696998.2024.2404361
- Citations
- 4
- Primary Topic
- Blood transfusion and management
- Type
- article
- Field-Weighted Citation Impact
- 0.89